Prevalence and characteristics of the catecholamine induced QT prolongation syndrome

30 August 2024 (08:00 - 17:30)

Organised by:

Sign in for access options

Sign in to view the resources

Sign in for access options

About the speaker

Professor Vincent Probst

University Hospital of Nantes, Nantes (France)

5 More presentations in this session

Presentation thumbnail

Role of ventricular tachycardia cycle length in the outcomes after catheter ablation or antiarrhythmic drugs in the SURVIVE-VT trial

Doctor P. Avila Alonso (Madrid, ES)

Abstract Slides Video

Presentation thumbnail

High incidence of malignant arrhythmias and heart failure in patients with RBM20-associated cardiomyopathy: a multicenter cohort study and review of the literature

Mr M. Tukker (Rotterdam, NL)

Abstract Slides Video

Presentation thumbnail

Significance of J wave with inverted ST-T polarity induced by ill-timed atrial premature beats and its association with Torsade de Pointes in patients with acute acquired long QT syndrome

Doctor H. Ichiryu (Gifu, JP)

Abstract Slides Video

Presentation thumbnail

Comorbidities and use of proarrhythmic drugs in patients with torsade de pointes arrhythmia

Doctor K. Nowinski (Stockholm, SE)

Abstract Slides Video

Presentation thumbnail

Identification of genetic variants by using a whole exome sequencing approach in Taiwanese patients with Brugada Syndrome

Doctor J. Juang (Taipei, TW)

Abstract Slides Video

Access the full session

Session thumbnail

Sudden cardiac death: insight

The Event

Event poster

ESC Congress 2024

30 August - 2 September 2024

You may be interested in

Congress Presentation

When to consider device therapy in HFrEF - discussion

Congress Session

Ventricular storm (2)

Congress Presentation

Case 2 - implantable cardioverter defibrillator, catheter ablation, or both for secondary prevention?

ESC 365 is supported by

novartis

Explore sponsored resources

ESC 365 is supported by

novartis

Explore sponsored resources